Octreotide for the treatment of chylothorax in two preterm infants

被引：0
|
作者：
Haase, R. [1 ]
Lieser, U. [1 ]
Buttenhoff, S. [1 ]
Merkel, N. [1 ]
机构：
[1] Univ Halle Wittenberg, Univ Klin Kinder & Jungendmed, D-06097 Halle, Germany
来源：
MONATSSCHRIFT KINDERHEILKUNDE | 2011年 / 159卷 / 04期
关键词：
Chylothorax; Thoracotomy; Somatostatin; Octreotide; Premature birth; POSTOPERATIVE CHYLOTHORAX; PLEURAL EFFUSIONS; NEONATAL-PERIOD; CHILDREN; SOMATOSTATIN; MANAGEMENT;
D O I：
10.1007/s00112-010-2358-2
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
In recent years the use of somatostatin (SST) or its analogue octreotide (OCT) has been described for the treatment of refractory chylothorax in neonates. Indication, dose and length of treatment are not precisely defined as yet. To date only few cases of OCT or SST use in preterm infants with a gestational age < 32 weeks have been published. Treatment was successful in these patients without serious adverse effects. We report two preterm (gestational age 27 and 25 weeks) infants with chylothorax following surgical ligation of a patent arterial duct. Both patients were treated successfully with OCT (96 A mu g/kg per day).
引用
收藏
页码：364 / 367
页数：4
相关论文
共 50 条
  • [41] Somatostatin or octreotide as treatment options for chylothorax in young children:: a systematic review
    Roehr, C
    Jung, A
    Proquitté, H
    Blankenstein, O
    Hammer, H
    Lakhoo, K
    Wauer, RR
    INTENSIVE CARE MEDICINE, 2006, 32 (05) : 650 - 657
  • [42] Octreotide, a Somatostatin Analogue, in the Treatment of Chylothorax Associated with Idiopathic Fibrosing Mediastinitis
    Togashi, Yosuke
    Kim, Young Hak
    Miyahara, Ryo
    Irisa, Kaoru
    Sakamori, Yuichi
    Masago, Katsuhiro
    Mio, Tadashi
    Date, Hiroshi
    Mishima, Michiaki
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 222 (01): : 51 - 53
  • [43] Efficacy and Predictor of Octreotide Treatment for Postoperative Chylothorax After Thoracic Esophagectomy
    Takeo Fujita
    Hiroyuki Daiko
    World Journal of Surgery, 2014, 38 : 2039 - 2045
  • [44] Octreotide for conservative management of postoperative chylothorax
    Andrés, AGC
    Fernández, CM
    Díez, FJM
    Gude, VDH
    Antón, JAP
    de Nicolás, JLM
    ARCHIVOS DE BRONCONEUMOLOGIA, 2004, 40 (10): : 473 - 475
  • [45] Idiopathic congenital chylothorax treated with octreotide
    Sousa, P. Rego
    Leitao, H.
    Camacho, C.
    Nunes, J. L.
    Kirsten, G.
    PROCEEDINGS OF THE 8TH WORLD CONGRESS OF PERINATAL MEDICINE, 2007, : 703 - +
  • [46] A Case of Congenital Chylothorax Treated with Octreotide
    Ozdemir, Ozmert Muhammet Ali
    Ergin, Hacer
    Kucuktasci, Kazim
    Sahin, Ozlem
    Corduk, Nergul
    Karadagli, Eda
    Yildirim, Basak
    GUNCEL PEDIATRI-JOURNAL OF CURRENT PEDIATRICS, 2015, 13 (01): : 68 - 71
  • [47] Spontaneous neonatal chylothorax treated with octreotide
    Siu, SL
    Lam, DS
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2006, 42 (1-2) : 65 - 67
  • [48] Octreotide as a therapeutic option for management of chylothorax
    Al-Zubairy, SA
    Al-Jazairi, AS
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (05) : 679 - 682
  • [49] Severe congenital chylothorax treated with octreotide
    Young S.
    Dalgleish S.
    Eccleston A.
    Akierman A.
    McMillan D.
    Journal of Perinatology, 2004, 24 (3) : 200 - 202
  • [50] Octreotide for persistent chylothorax in a pediatric patient
    Ottinger, JG
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (06) : 1106 - 1107
12345